Molecular mechanism of inhibitory effects of CD59 gene on atherosclerosis in ApoE (-/-) mice

Immunology Letters

Volumn 156, Issue 1-2, 2013, Pages 68-81

  Li, Bing ^a   Xu, Ying Jie ^a   Chu, Xian Ming ^a   Gao, Mei Hua ^a   Wang, Xiu Hai ^a   Nie, Shu Min ^a   Yang, Fan ^a   Lv, Cong Yi ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

ApoE ( ) mice; Atherosclerosis; CD59; Mechanism

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; CD59 ANTIGEN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; FAS ANTIGEN; GELATINASE A; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; PROTEIN BCL 2; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CD59 GENE; CELL CYCLE REGULATION; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

APOE (-/-) MICE; APOE KNOCKOUT MICE; AS; ATHEROSCLEROSIS; AVIDIN-BIOTIN COMPLEX; CD59; CDK4; CYCLIN DEPENDENT PROTEIN KINASE 4; DAB; DIAMINOBENZIDINE; GLYCOSYLPHOSPHATIDYL INOSITOL; GPI; HDL; HE; HEMATOXYLIN/EOSIN; HIGH-DENSITY LIPOPROTEIN; INTEGRATED OPTICAL DENSITY; IOD; LDL; LOW DENSITY LIPOPROTEIN; MAC; MECHANISM; MEMBRANE ATTACK COMPLEX; POLYVINYLIDENE FLUORIDE (PVDF) MEMBRANES; PVDF; SABC; SMC; SMOOTH MUSCLE CELL; TC; TG; TOTAL CHOLESTEROL; TRIGLYCERIDE;

ANIMALS; ANTIGENS, CD59; ANTIGENS, CD95; AORTA; APOLIPOPROTEINS E; APOPTOSIS; ATHEROSCLEROSIS; BLOTTING, WESTERN; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MATRIX METALLOPROTEINASE 2; MICE; MICE, KNOCKOUT; PLASMIDS; PROTO-ONCOGENE PROTEINS C-BCL-2; RANDOM ALLOCATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 84885822533     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2013.09.025     Document Type: Article

References (45)

1. Saely C.H., Drexel H., Sourij H., Aczel S., Jahnel H., ZweikerR, et al. Key role of postchallenge hyperglycemia for the presence and extent of coronary atherosclerosis: an angiographic study. Atherosclerosis 2008, 199:317-322.
2. Li B., Gao M.H., Zhang X.C., Chu X.M. Molecular immune mechanism of C-phycocyanin from Spirulina platensis induces apoptosis in HeLa cells in vitro. Biotechnol Appl Biochem 2006, 43:155-164.
3. Matsuura E., Kobayashi K., Tabuchi M., Lopez L.R. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Prog Lipid Res 2006, 45:466-486.
4. Li B., Zhang X., Gao M., Chu X. Effects of CD59 on antitumoral activities of phycocyanin from Spirulina platensis. Biomed Pharmacother 2005, 59:551-560.
5. Shan Z., Yao C., Li Z.L., Teng Y., Li W., Wang J.S., et al. Differentially expressed microRNAs at different stages of atherosclerosis in ApoE-deficient mice. Chin Med J (Engl) 2013, 126:515-520.
6. Brooimans R.A., van Wieringen P.A., van Es L.A., Daha M.R. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis. Eur J Immunol 1992, 22:3135-3140.
7. Li B., Chu X., Gao M., Li W. Apoptotic mechanism of MCF-7 breast cells in vivo and in vitro induced by photodynamic therapy with C-phycocyanin. Acta Biochim Biophys Sin (Shanghai) 2010, 42:80-89.
8. Wu X., Kang J., Xie C., Burris R., Ferguson M.E., Badger T.M., et al. Dietary blueberries attenuate atherosclerosis in apolipoprotein E-deficient mice by upregulating antioxidant enzyme expression. J Nutr 2010, 140:1628-1632.
9. Murray E.W., Robbins S.M. Antibody cross-linking of the glycosylphosphatidylinositol-linked protein CD59 on hematopoietic cells induces signaling pathways resembling activation by complement. J Biol Chem 1998, 273:25279-25284.
10. Walsh L.A., Tone M., Thiru S., Waldmann H. The CD59 antigen - a multifunctional molecule. Tissue Antigens 1992, 40:213-220.
11. Zhang J., Hu W., Xing W., You T., Xu J., Qin X., et al. The protective role of CD59 and pathogenic role of complement in hepatic ischemia and reperfusion injury. Am J Pathol 2011, 179:2876-2884.
12. Miyagawa S., Shirakura R., Matsumiya G., Nakata S., Matsuda H., Hatanaka M., et al. Possibility of prevention of hyperacute rejection by DAF and CD59 in xenotransplantation. Transplant Proc 1994, 26:1235-1238.
13. Wu G., Chen T., Shahsafaei A., Hu W., Bronson R.T., Shi G.P., et al. Complement regulator CD59 protects against angiotensin II-induced abdominal aortic aneurysms in mice. Circulation 2010, 121:1338-1346.
14. An G., Miwa T., Song W.L., Lawson J.A., Rader D.J., Zhang Y., et al. CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice. Mol Immunol 2009, 46:1702-1709.
15. Guo X., Yamada S., Tanimoto A., Ding Y., Wang K.Y., Shimajiri S., et al. Overexpression of peroxiredoxin 4 attenuates atherosclerosis in apolipoprotein E knockout mice. Antioxid Redox Signal 2012, 17:1362-1375.
16. Li J.M., Gao M.H., Zhang B. Inhibition of mutant CD59 protein on proliferation of ovarian cancer A2780 cells. Ai Zheng 2009, 28:379-383.
17. Ninomiya H., Stewart B.H., Rollins S.A., Zhao J., Bothwell A.L., Sims P.J. Contribution of the N-linked carbohydrate of erythrocyte antigen CD59 to its complement-inhibitory activity. J Biol Chem 1992, 267:8404-8410.
18. Nuutila J., Jalava-Karvinen P., Hohenthal U., Kotilainen P., Pelliniemi T.T., Nikoskelainen J., et al. Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections. Hum Immunol 2013, 74:522-530.
19. Tallman M.S., Rowlings P.A., Milone G., Zhang M.J., Perez W.S., Weisdorf D., et al. Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission. Blood 2000, 96:1254-1258.
20. Zacharias D.A., Mullen M., Planey S.L. Antiproliferative factor-induced changes in phosphorylation and palmitoylation of cytoskeleton-associated protein-4 regulate its nuclear translocation and DNA binding. Int J Cell Biol 2012, 2012:150918.
21. Elkan A.C., Anania C., Gustafsson T., Jogestrand T., Hafstrom I., Frostegard J. Diet and fatty acid pattern among patients with SLE: associations with disease activity, blood lipids and atherosclerosis. Lupus 2012, 21:1405-1411.
22. Lin Y.T., Huang A.C., Kuo C.L., Yang J.S., Lan Y.H., Yu C.C., et al. Induction of cell cycle arrest and apoptosis in human osteosarcoma U-2 OS cells by Solanum lyratum extracts. Nutr Cancer 2013, 65:469-479.
23. Yang P.Y., Chen M.F., Tsai C.H., Hu D.N., Chang F.R., Wu Y.C. Involvement of caspase and MAPK activities in norcantharidin-induced colorectal cancer cell apoptosis. Toxicol In Vitro 2010, 24:766-775.
24. Zhao X.H., Wang X.L., Li X.Y. Automobile exhaust particle-induced apoptosis and necrosis in MRC-5 cells. Toxicol Lett 2001, 122:103-110.
25. Jahanshahi M., Nickmahzar E.G., Babakordi F. The effect of Ginkgo biloba extract on scopolamine-induced apoptosis in the hippocampus of rats. Anat Sci Int 2013, 88:217-222.
26. Luo Q., Li X., Li J., Kong X., Zhang J., Chen L., et al. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer. Int J Oncol 2013, 43:1212-1218.
27. Montillo M., Ricci F., Tedeschi A., Cafro A.M., Nosari A.M., Nichelatti M., et al. Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia. Leuk Res 2009, 33:1072-1078.
28. Hu X., Li W., Liu G., Wu H., Gao Y., Chen S., et al. The effect of Bcl-2 siRNA combined with miR-15a oligonucleotides on the growth of Raji cells. Med Oncol 2013, 30:430.
29. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008, 9:47-59.
30. Saxena N., Yadav P., Kumar O. The fas/fas ligand apoptotic pathway is involved in abrin-induced apoptosis. Toxicol Sci 2013, 135:103-118.
31. Sahinarslan A., Boyaci B., Kocaman S.A., Topal S., Ercin U., Okyay K., et al. The relationship of serum soluble Fas ligand (sFasL) level with the extent of coronary artery disease. Int J Angiol 2012, 21:29-34.
32. Esparza L., De Haro J., Bleda S., Acin F. Non-Fas(CD95/APO1)-mediated apoptosis of activated T cells inhibits the development of atherosclerosis. Interact Cardiovasc Thorac Surg 2012, 15:340-343.
33. Jiang Y.R., Miao Y., Yang L., Xue M., Guo C.Y., Ma X.J., et al. Effect of chinese herbal drug-containing serum for activating-blood and dispelling-toxin on ox-LDL-induced inflammatory factors' expression in endothelial cells. Chin J Integr Med 2012, 18:30-33.
34. Kong W., Zhu Y. The pleiotropic effects of statins in the prevention of atherosclerosis: Editorial to: "Simvastatin suppresses apoptosis in vulnerable atherosclerotic plaques through regulating the expression of p53, Bcl-2 en Bcl-xL" by Weiwei Qin et al. Cardiovasc Drugs Ther 2012, 26:5-7.
35. Gross A., McDonnell J.M., Korsmeyer S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999, 13:1899-1911.
36. Kaparou M., Choumerianou D., Perdikogianni C., Martimianaki G., Kalmanti M., Stiakaki E. Enhanced levels of the apoptotic BAX/BCL-2 ratio in children with acute lymphoblastic leukemia and high-risk features. Genet Mol Biol 2013, 36:7-11.
37. Nadzialek S., Pigneur L.M., Weron B., Kestemont P. Bcl-2 and Caspase 3 mRNA levels in the testes of gudgeon, Gobio gobio, exposed to ethinylestradiol (EE2). Aquat Toxicol 2010, 98:304-310.
38. Jones S., Fernandes N.V., Yeganehjoo H., Katuru R., Qu H., Yu Z., et al. Beta-ionone induces cell cycle arrest and apoptosis in human prostate tumor cells. Nutr Cancer 2013, 65:600-610.
39. Braga L.E., Granja M.G., da Silva G.M., Giestal-de-Araujo E., Santos A.A. PMA increases M3 muscarinic receptor levels and decreases retinal cells proliferation through a change in the levels of cell-cycle regulatory proteins. Neurosci Lett 2013, 550:29-34.
40. 1 promoter. BMC Cancer 2012, 12:267.
41. Choi B.K., Cha B.Y., Yagyu T., Woo J.T., Ojika M. Sponge-derived acetylenic alcohols, petrosiols, inhibit proliferation and migration of platelet-derived growth factor (PDGF)-induced vascular smooth muscle cells. Bioorg Med Chem 2013, 21:1804-1810.
42. Dabek J., Glogowska-Ligus J., Szadorska B. Transcription activity of MMP-2 and MMP-9 metalloproteinase genes and their tissue inhibitor (TIMP-2) in acute coronary syndrome patients. J Postgrad Med 2013, 59:115-120.
43. Sugita Y., Mazda T., Tomita M. Amino-terminal amino acid sequence and chemical and functional properties of a membrane attack complex-inhibitory factor from human erythrocyte membranes. J Biochem 1989, 106:589-592.
44. Ortak H., Demir S., Ates O., Sogut E., Alim S., Benli I. Association of MMP2-1306C/T and TIMP2G-418C polymorphisms in retinal vein occlusion. Exp Eye Res 2013, 113:151-155.
45. Yongxin S., Wenjun D., Qiang W., Yunqing S., Liming Z., Chunsheng W. Heavy smoking before coronary surgical procedures affects the native matrix metalloproteinase-2 and matrix metalloproteinase-9 gene expression in saphenous vein conduits. Ann Thorac Surg 2013, 95:55-61.